Amneal Pharmaceuticals (AMRX) Insider Trading & Ownership $7.96 +0.18 (+2.31%) As of 06/12/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Amneal Pharmaceuticals (NASDAQ:AMRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage26.56%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$44.13M Get AMRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Amneal Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AMRX Insider Buying and Selling by Quarter Amneal Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/14/2025Tushar Bhikhubhai PatelMajor ShareholderSell5,000,000$8.35$41,750,000.00 3/3/2025Gautam PatelDirectorSell80,000$8.90$712,000.00 2/3/2025Gautam PatelDirectorSell80,000$8.14$651,200.00 1/8/2025Gautam PatelDirectorSell62,590$8.01$501,345.90 1/2/2025Gautam PatelDirectorSell17,410$8.01$139,454.10 11/15/2024Jason B DalySVPSell43,657$8.61$375,886.77 (Data available from 1/1/2013 forward) AMRX Insider Trading Activity - Frequently Asked Questions Who is on Amneal Pharmaceuticals's Insider Roster? The list of insiders at Amneal Pharmaceuticals includes Andrew S Boyer, Gautam Patel, Jason B Daly, Tpg Gp A, Llc, and Tushar Bhikhubhai Patel. Learn more on insiders at AMRX. What percentage of Amneal Pharmaceuticals stock is owned by insiders? 26.56% of Amneal Pharmaceuticals stock is owned by insiders. Learn more on AMRX's insider holdings. Which Amneal Pharmaceuticals insiders have been selling company stock? The following insiders have sold AMRX shares in the last 24 months: Andrew S Boyer ($121,017.26), Gautam Patel ($2,004,000.00), Jason B Daly ($375,886.77), and Tushar Bhikhubhai Patel ($41,750,000.00). How much insider selling is happening at Amneal Pharmaceuticals? Insiders have sold a total of 5,312,959 Amneal Pharmaceuticals shares in the last 24 months for a total of $44,250,904.03 sold. Amneal Pharmaceuticals Key ExecutivesMr. Chirag K. Patel (Age 57)Co-Founder, Co-CEO, President & Director Compensation: $1.71MMr. Chintu Patel R.Ph. (Age 52)Co-Founder, Co-CEO & Director Compensation: $1.7MMr. Anastasios G. Konidaris (Age 57)Executive VP & CFO Compensation: $1.04MMr. Jason B. Daly Esq. (Age 50)Senior VP, Chief Legal Officer & Corporate Secretary Compensation: $779.06kMs. Nikita Shah (Age 45)Executive VP & Chief Human Resources Officer Compensation: $848.83kMr. Andrew S. Boyer (Age 58)Executive VP & Chief Commercial Officer of Generics Compensation: $1.2MMr. Anthony DiMeoHead of Investor RelationsMr. Gregory SgammatoSenior Vice President of Corporate DevelopmentMr. Pranav MehtaSenior VP of Strategic Sourcing & Supply ManagementDr. Sanjay Kumar Jain Ph.D.Chief Quality Officer More Insider Trading Tools from MarketBeat Related Companies BPMC Insider Trading ROIV Insider Trading RVMD Insider Trading VRNA Insider Trading BBIO Insider Trading ELAN Insider Trading GRFS Insider Trading TGTX Insider Trading NUVL Insider Trading LNTH Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders Bought This page (NASDAQ:AMRX) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amneal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amneal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
